Skip to main content

Table 2 Characteristics of surgical group and non surgical group

From: Short-term survival and safety of apatinib combined with oxaliplatin and S-1 in the conversion therapy of unresectable gastric cancer

Variable

Surgical group,

N (%)

Non Surgical group,

N (%)

Efficacy evaluation

 CR

1 (4.5)

0 (0)

 PR

18 (81.8)

9 (42.9)

 SD

3 (13.7)

0 (0)

 PD

0 (0)

7 (57.1)

Unresectable factors

 N3 lymph node metastasis

2 (9.1)

0 (0)

 Distant lymphatic metastasis

2 (9.1)

2 (12.4)

 Invasion of peripheral organs (T4b)

3 (13.7)

1 (6.3)

 Liver metastasis

1 (4.5)

1 (6.3)

 Peritoneal carcinomatosis

14 (63.6)

12 (75.0)